Fusion Pharmaceuticals Inc. (FUSN): Price and Financial Metrics


Fusion Pharmaceuticals Inc. (FUSN): $8.15

-0.46 (-5.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

FUSN Stock Price Chart Interactive Chart >

Price chart for FUSN

FUSN Price/Volume Stats

Current price $8.15 52-week high $19.00
Prev. close $8.61 52-week low $6.61
Day low $8.09 Volume 49,600
Day high $8.78 Avg. volume 44,232
50-day MA $8.70 Dividend yield N/A
200-day MA $11.32 Market Cap 346.02M

Fusion Pharmaceuticals Inc. (FUSN) Company Bio


Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant and is headquartered in Hamilton, Canada.


FUSN Latest News Stream


Event/Time News Detail
Loading, please wait...

FUSN Latest Social Stream


Loading social stream, please wait...

View Full FUSN Social Stream

Latest FUSN News From Around the Web

Below are the latest news stories about Fusion Pharmaceuticals Inc that investors may wish to consider to help them evaluate FUSN as an investment opportunity.

Fusion Pharmaceuticals Appoints Isabelle Dussault, Ph.D. as Senior Vice President, Research

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), today announced the appointment of Isabelle Dussault, Ph.D. as senior vice president, research.

BioSpace | June 6, 2021

Fusion Pharmaceuticals Inks Manufacturing Deal with McMaster University

Fusion Pharmaceuticals (FUSN) has teamed up with McMaster University to set up a radiopharmaceutical manufacturing facility in Hamilton. The arrangement involves a 15-year lease agreement with the university. The university will be responsible for building the facility while Fusion will take care of equipping and validating it. The parties are working on getting the plant operating by early 2024. The facility will offer 27,000 square feet of space and be current Good Manufacturing Practice (GMP) compliant. "We will continue to prioritize manufacturing and supply chain infrastructure in our long-term plans, and this facility is an important milestone in executing those plans,” commented Fusion CEO John Valliant.

Neha Gupta on TipRanks | June 3, 2021

New radiopharmaceutical manufacturing facility coming to McMaster Innovation Park

McMaster University and Fusion Pharmaceuticals say they are working together to build a radiopharmaceutical manufacturing facility in west Hamilton.

Global News Canada | June 2, 2021

Fusion Pharmaceuticals Enters into Agreement to Build Radiopharmaceutical Manufacturing Facility

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced it entered a 15-year lease agreement with Hamilton, Ontario-based McMaster University to build a 27,000 square foot current Good Manufacturing Practice (GMP

BioSpace | June 1, 2021

Fusion Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 11:00am EDT.

BioSpace | May 26, 2021

Read More 'FUSN' Stories Here

FUSN Price Returns

1-mo -0.31%
3-mo -31.40%
6-mo -37.74%
1-year N/A
3-year N/A
5-year N/A
YTD -30.64%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7428 seconds.